Consolidated Statements of Equity - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings (Accumulated Deficit) [Member]	Retained Earnings (Accumulated Deficit) [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Accumulated Other Comprehensive Loss [Member]
Beginning balance at Mar. 28, 2020	$ 474,315	$ (245)	$ 1,570	$ 485,552	$ (48)	$ (245)	$ (12,759)
Beginning balance, shares at Mar. 28, 2020			56,665
Net income	$ 84,899				84,899
Accounting Standards Update [Extensible List]	Accounting Standards Update 2016-13 [Member]
Equity-based compensation	$ 6,037			6,037
Net common stock issued under equity-based compensation plans	(1,630)		$ (1)	79	(1,708)
Net common stock issued under equity-based compensation plans, shares			(25)
Foreign currency translation adjustments	5,235						5,235
Ending balance at Apr. 03, 2021	568,611		$ 1,569	491,668	82,898		(7,524)
Ending balance, shares at Apr. 03, 2021			56,640
Net income	248,044				248,044
Equity-based compensation	9,777			9,777
Net common stock issued under equity-based compensation plans	(1,635)		$ 4	1,401	(3,040)
Net common stock issued under equity-based compensation plans, shares			198
Foreign currency translation adjustments	316						316
Ending balance at Apr. 02, 2022	825,113		$ 1,573	502,846	327,902		(7,208)
Ending balance, shares at Apr. 02, 2022			56,838
Net income	401,802				401,802
Equity-based compensation	14,160			14,160
Net common stock issued under equity-based compensation plans	(1,547)		$ 12	2,473	(4,032)
Net common stock issued under equity-based compensation plans, shares			270
Foreign currency translation adjustments	(6,527)						(6,527)
Ending balance at Apr. 01, 2023	$ 1,233,001		$ 1,585	$ 519,479	$ 725,672		$ (13,735)
Ending balance, shares at Apr. 01, 2023			57,108